| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 363,4 k € | +14.9% | 316,2 k € | +173.5% | 115,6 k € | -51.4% | 238,1 k € | -44.4% | 428,2 k € | -66.1% | 1,3 M € | +48.7% | 850,2 k € | -23.9% | 1,1 M € | +84.7% | 605,1 k € | -19.1% | 748,2 k € | +12.4% | 666,0 k € | +40.6% | 473,8 k € | -87.3% | 3,7 M € | -5.2% | 3,9 M € | +390.4% | 804,6 k € | -42.8% | 1,4 M € | -30.6% | 2,0 M € | -36.7% | 3,2 M € | |
| EBITDA | -397,5 k € | +15.2% | -468,9 k € | +69.4% | -1,5 M € | -78.1% | -858,9 k € | +8.0% | -933,1 k € | +68.2% | -2,9 M € | -603.6% | -417,2 k € | +88.4% | -3,6 M € | -134.6% | -1,5 M € | -17983.3% | 8,6 k € | +100.8% | -1,0 M € | -81.8% | -564,4 k € | -110.9% | 5,2 M € | +203.9% | 1,7 M € | -51.6% | 3,5 M € | +52.6% | 2,3 M € | +23.2% | 1,9 M € | -29.5% | 2,6 M € | |
| Operating profit | -432,8 k € | +15.9% | -514,8 k € | +67.1% | -1,6 M € | -72.6% | -906,8 k € | +7.0% | -975,6 k € | +67.4% | -3,0 M € | -457.2% | -537,5 k € | +85.7% | -3,8 M € | -121.4% | -1,7 M € | -978.8% | -157,6 k € | +86.8% | -1,2 M € | -77.8% | -671,1 k € | -113.4% | 5,0 M € | +233.0% | 1,5 M € | -54.7% | 3,3 M € | +56.4% | 2,1 M € | +26.4% | 1,7 M € | -33.3% | 2,5 M € | |
| Profit/loss | -81,4 k € | -114.3% | 570,4 k € | +143.3% | -1,3 M € | -70.9% | -770,7 k € | +87.5% | -6,2 M € | -160.5% | -2,4 M € | +46.2% | -4,4 M € | -1257.9% | 380,4 k € | -84.5% | 2,5 M € | +2059.5% | 114,0 k € | -95.4% | 2,5 M € | +1125.3% | 203,0 k € | -95.5% | 4,5 M € | +161.5% | 1,7 M € | -39.4% | 2,8 M € | +48.3% | 1,9 M € | -16.7% | 2,3 M € | +46.3% | 1,6 M € | |
| Equity | 11,7 M € | -0.7% | 11,8 M € | +5.1% | 11,2 M € | -10.5% | 12,6 M € | -5.8% | 13,3 M € | -31.6% | 19,5 M € | -10.8% | 21,9 M € | -16.8% | 26,3 M € | +1.5% | 25,9 M € | +10.5% | 23,4 M € | +0.5% | 23,3 M € | +11.9% | 20,8 M € | +1.0% | 20,6 M € | +28.0% | 16,1 M € | +12.0% | 14,4 M € | +24.7% | 11,5 M € | +20.0% | 9,6 M € | +31.6% | 7,3 M € | |
| Total assets | 11,8 M € | -0.6% | 11,9 M € | +5.0% | 11,3 M € | -11.1% | 12,7 M € | -5.6% | 13,4 M € | -31.3% | 19,6 M € | -11.0% | 22,0 M € | -16.6% | 26,4 M € | -0.4% | 26,5 M € | +8.3% | 24,5 M € | +4.1% | 23,5 M € | +9.7% | 21,4 M € | +3.1% | 20,8 M € | +26.5% | 16,4 M € | +13.3% | 14,5 M € | +19.5% | 12,1 M € | +21.4% | 10,0 M € | +26.2% | 7,9 M € | |
| Cash | 417,2 k € | +47.6% | 282,6 k € | -3.6% | 293,2 k € | -49.4% | 579,1 k € | -73.6% | 2,2 M € | -5.0% | 2,3 M € | -11.8% | 2,6 M € | -46.4% | 4,9 M € | -39.3% | 8,0 M € | +160.9% | 3,1 M € | -5.0% | 3,2 M € | +81.2% | 1,8 M € | +47.6% | 1,2 M € | -27.8% | 1,7 M € | -26.5% | 2,3 M € | +34.9% | 1,7 M € | +192.9% | 578,4 k € | +89.1% | 305,8 k € | |
| Debts | 52,4 k € | +7.4% | 48,8 k € | -7.6% | 52,8 k € | -62.4% | 140,3 k € | +65.8% | 84,6 k € | +43.4% | 59,0 k € | -47.8% | 112,9 k € | +26.2% | 89,5 k € | -84.8% | 587,1 k € | -42.0% | 1,0 M € | +518.9% | 163,6 k € | -72.0% | 584,0 k € | +332.6% | 135,0 k € | -54.3% | 295,6 k € | +195.7% | 100,0 k € | -83.1% | 590,3 k € | +58.6% | 372,3 k € | -38.5% | 604,9 k € | |
| Staff | 3,2 | 2,8 | 2,6 | 3,2 | 3,7 | 3,8 | 3,7 | 4,1 | 3,8 | 3,7 | 3,8 | 4,7 | 5,3 | 4,9 | 4,7 | 7 | 7 | 6,1 | ||||||||||||||||||
Non-profit organization · Leuven · incorporated on 02/06/1988 · 3,2 ETP
Non-profit organization loss-making in the latest fiscal year. Cash position rising (+47.6%).
Solid counterparty for a standard engagement.
Life Sciences Research Partners is a Non-profit organization incorporated in 1988. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven. It employs on average 3,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette